Table 1 Baseline demographic and clinical characteristics of study participants
Variable | Centre 1, n = 56 | Centre 2, n = 21 | Total, n = 77 |
|---|---|---|---|
Age, mean (SD) | 53.8 (10.9) | 58.7 (11.1) | 55.1 (11.1) |
Married, n (%) | 38 (67.9) | 16 (76.2) | 54 (70.1) |
Highest level of education, n (%) | |||
 Less than college/university | 11 (19.6) | 4 (19.0) | 15 (19.5) |
 College/university or higher | 39 (69.6) | 17 (81.0) | 66 (85.7) |
 Prefer not to respond | 6 (10.7) | 0 | 6 (7.8) |
Combined household income, n (%) | |||
 < $60 k | 19 (33.9) | 5 (25.0) | 24 (31.2) |
 $60–99 k | 10 (17.9) | 5 (25.0) | 15 (19.5) |
 > 100 k | 11 (19.6) | 5 (25.0) | 16 (21.1) |
 Prefer not to respond | 16 (28.6) | 5 (25.0) | 21 (27.6) |
Employment status, n (%) | |||
 Employed (working or on sick leave) | 31 (55.4) | 10 (47.6) | 41 (53.2) |
 Unemployed or retired | 20 (35.7) | 10 (47.6) | 30 (39.0) |
Stage, n (%) | |||
 Stage I | 6 (10.7) | 3 (15.0) | 9 (11.8) |
 Stage II | 25 (44.6) | 5 (25.0) | 30 (39.5) |
 Stage III | 25 (44.6) | 12 (60.0) | 37 (48.7) |
Treatment intent, n (%) | |||
 Adjuvant | 42 (75.0) | 14 (70.0) | 56 (73.7) |
 Neoadjuvant | 14 (25.0) | 6 (30.0) | 20 (26.3) |
Regimen, n (%) | |||
 AC-P | 30 (53.6) | 15 (60.0) | 45 (58.4) |
 FEC-100 | 3 (5.4) | 5 (25.0) | 8 (10.5) |
 FEC-T | 12 (21.4) | 0 | 12 (15.6) |
 TC | 10 (17.9) | 0 | 10 (13.2) |
 Other | 1 (1.8) | 1 (5.0) | 2 (2.6) |
Primary G-CSF prophylaxis, n (%) | 50 (89.2) | 9 (42.9) | 59 (76.6) |
Central line, n (%) | 20 (35.7) | 5 (23.8) | 25 (32.5) |
Co-morbidities, n (%) | |||
 Cardiovascular disease | 3 (5.4) | 2 (9.5) | 5 (6.5) |
 Chronic lung disease | 3 (5.4) | 1 (4.8) | 4 (5.2) |
 Diabetes | 4 (7.1) | 2 (9.5) | 6 (7.8) |
 Moderate to severe kidney disease | 1 (1.8) | 1 (4.8) | 2 (2.6) |